Last week, an FDA advisory panel unanimously agreed that Phenylephrine, a common ingredient in many over-the-counter decongestant medications, is ineffective. The decision could affect hundreds of products including Sudafed PE, NyQuil Severe Cold and Flu, and Benadryl Allergy Plus Congestion. This comes as COVID cases continue to rise and as we head into fall allergy season. Studies also show that human-caused climate change is making allergies more intense and last longer. For this edition of In Good Health, our panel of experts discusses the best alternatives for relief and how you should prepare for the colder months as sicknesses surge.Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Find out how to connect with us by visiting our website.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy